Glutamatergic hyperfunctioning during alcohol withdrawal syndrome: Therapeutic perspective with zinc and magnesium
dc.contributor.author | Prior, Pedro Luis [UNIFESP] | |
dc.contributor.author | Galduróz, José Carlos Fernandes [UNIFESP] | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.date.accessioned | 2016-01-24T14:17:07Z | |
dc.date.available | 2016-01-24T14:17:07Z | |
dc.date.issued | 2011-09-01 | |
dc.description.abstract | It is known that the glutamatergic pathways are hyperfunctioning during alcohol withdrawal syndrome. It has been demonstrated that hyperfunctioning of this system causes a great damage to the superior cortical activity, the ability to concentrate and the control of impulses. Recent studies show that the cations zinc and magnesium modulate the glutamatergic function, reducing it to non-toxic levels, yet not reducing it to the point of depriving this neurotransmitter of its normal activity. New perspectives of treatment focus on the modulation of this system, having, as a result, reestablishment of impulse control abilities, damage prevention to the hippocampus and the amygdala and prevention of future relapses. (C) 2011 Elsevier B.V. All rights reserved. | en |
dc.description.affiliation | Universidade Federal de São Paulo, Dept Psychobiol, BR-04024002 São Paulo, Brazil | |
dc.description.affiliation | Universidade Federal de São Paulo, Dept Med, BR-04024002 São Paulo, Brazil | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Dept Psychobiol, BR-04024002 São Paulo, Brazil | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Dept Med, BR-04024002 São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.format.extent | 368-370 | |
dc.identifier | http://dx.doi.org/10.1016/j.mehy.2011.05.017 | |
dc.identifier.citation | Medical Hypotheses. Edinburgh: Churchill Livingstone, v. 77, n. 3, p. 368-370, 2011. | |
dc.identifier.doi | 10.1016/j.mehy.2011.05.017 | |
dc.identifier.file | WOS000295183500014.pdf | |
dc.identifier.issn | 0306-9877 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/33973 | |
dc.identifier.wos | WOS:000295183500014 | |
dc.language.iso | eng | |
dc.publisher | Churchill Livingstone | |
dc.relation.ispartof | Medical Hypotheses | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | Glutamatergic hyperfunctioning during alcohol withdrawal syndrome: Therapeutic perspective with zinc and magnesium | en |
dc.type | info:eu-repo/semantics/article |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- WOS000295183500014.pdf
- Tamanho:
- 494.92 KB
- Formato:
- Adobe Portable Document Format
- Descrição: